Understanding how specific proteins influence eye development to prevent blindness
Molecular Determinants for WDR5-Driven Transcriptional Regulation at Lineage-Specifying Genes During Retinogenesis
This study is looking at how a protein called WDR5 helps develop retinal cells from stem cells, which could lead to new treatments for retinal blindness that affects many people.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10888320 on NIH RePORTER |
What this research studies
This research investigates the role of WDR5, a protein that modifies chromatin, in the development of retinal cells from embryonic stem cells. By examining how WDR5 interacts with other transcription factors like p53 and MAX, the study aims to uncover the mechanisms that lead to retinal development and potential blindness. The researchers will use advanced techniques, including CRISPR, to manipulate these proteins and observe their effects on cell fate determination during a critical period of eye development. This work could provide insights into new therapies for retinal blindness, which affects millions globally.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with retinal degeneration or genetic conditions that lead to blindness.
Not a fit: Patients with non-retinal related vision issues or those whose blindness is not linked to genetic factors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for retinal blindness, improving vision for affected patients.
How similar studies have performed: Other research has shown promising results using similar approaches to manipulate gene expression for therapeutic purposes, indicating potential for success in this area.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Rao, Rajesh C. — University of Michigan at Ann Arbor
- Study coordinator: Rao, Rajesh C.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.